市場調査レポート

商品コード

1571027

欧州の整形外科用生体材料市場：市場規模、動向および分析（2024年～2030年）：MedSuite

Orthopedic Biomaterials Market Size, Share and Trends Analysis | Europe | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, and 3 more

出版日: 2024年10月02日 | 発行: iData Research Inc.

| ページ情報: 英文 464 Pages | 納期: 即日から翌営業日

価格

PDF (Single User License)

USD 8,995 1,372,097円

レポートPDFを1名のみがご利用頂けるライセンスです。PDFファイルはDRM（デジタル著作権管理）付です。PDF内のテキスト等のコピー＆ペーストは可能です（編集は不可）。PDFの印刷はできません。

PDF (Site License)

USD 9,995 1,524,637円

レポートPDFを同じ国内の同じ事業所内で共有ご利用頂けるライセンスです。PDFファイルは、DRM(デジタル著作権管理システム)付です。PDF内のテキスト等のコピー＆ペーストは可能です（編集は不可）。　PDF内コンテンツの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Corporate License)

USD 10,995 1,677,177円

レポートPDFを同一企業の全世界の方にご使用頂けるライセンスです。ご利用人数に制限はありません。PDFファイルは、DRM(デジタル著作権管理システム)付です。PDF内のテキスト等のコピー＆ペーストは可能です（編集は不可）。PDF内コンテンツの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=152.54円

● ご注意事項

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

2023年、欧州の整形外科用生体材料の市場規模は、5億5,400万ユーロを超えました。同市場はCAGR2.1%で成長し、2030年には6億4,300万ユーロ近くに達すると予測されています。

主要な人口動態の動向が引き続き欧州の整形外科用生体材料市場を牽引しています。特筆すべき要因は、特に人口の高齢化に伴って脊椎の変形性関節症（OA）の発生率が上昇していることで、脊椎固定術の件数が増加しています。2008年に始まったベビーブーム世代の第一波の定年退職によって高齢化が進む中、関節炎や椎間板変性症に対処する治療に対する需要が高まっています。このため、骨移植代替物に対するニーズが高まっています。さらに、肥満率の上昇によって変性疾患の有病率はさらに加速しており、整形外科用生体材料と関連処置の需要を促進しています。これらの動向は、予測期間中の市場成長を促進すると予想されます。

Fidiaは、同社のHA関節内補充療法製品であるHyalubrix（R）とHyalgan（R）の好調な業績に支えられ、欧州の整形外科用生体材料市場における首位の座を維持しています。Medtronicは、主にINFUSE（TM）製品による整形外科用成長因子市場での優位性により、第2位にランクされました。Bioventusは、主に単回注射治療薬であるDUROLANE（R）の欧州全域における主要販売代理店として、第3位の市場シェアを確保しました。

当レポートでは、欧州の整形外科用生体材料市場について調査し、市場の概要とともに、セグメント別動向、COVID-19の影響分析、市場促進要因および阻害要因、競合市場シェア分析、および市場に参入する企業のプロファイルなどを提供しています。

イントロダクション
為替レート
市場概要とトレンド分析
促進要因と抑制要因
競争市場シェア分析
合併と買収
企業プロファイル
- Arthrex
- Biocomposites
- Bioventus
- DePuy Synthes
- Ferring Pharmaceuticals
- Isto Biologics
- Medtronic
- MTF
- NuVasive
- Orthofix
- Sanofi
- Stryker
- Terumo
- Vericel
- Zimmer Biomet
SWOT分析

国別プロファイル

イントロダクション
ドイツ
フランス
英国
イタリア
スペイン
ベネルクス
スカンジナビア
オーストリア
スイス
ポルトガル

手技件数

整形外科用骨移植代替品市場

整形外科用成長因子市場

整形外科用細胞治療市場

ヒアルロン酸関節内補充療法市場

整形外科用軟骨修復市場

図表

LIST OF CHARTS

Chart 1-1: Orthopedic Biomaterials Market by Segment, Europe, 2023
Chart 1-2: Orthopedic Biomaterials Market Overview, Europe, 2023 & 2030
Chart 2-1: Multi-Scenario Orthopedic Biomaterials Market Forecast, Europe, 2020 - 2030 (€M)
Chart 4-1: Orthopedic Biomaterials Market by Segment, Europe, 2020 - 2030
Chart 4-2: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023
Chart 5-1: Country Profile, Germany, 2023
Chart 5-2: Country Profile, France, 2023
Chart 5-3: Country Profile, United Kingdom, 2023
Chart 5-4: Country Profile, Italy, 2023
Chart 5-5: Country Profile, Spain, 2023
Chart 5-6: Country Profile, Benelux, 2023
Chart 5-7: Country Profile, Scandinavia, 2023
Chart 5-8: Country Profile, Austria, 2023
Chart 5-9: Country Profile, Switzerland, 2023
Chart 5-10: Country Profile, Portugal, 2023
Chart 7-1: Bone Graft Substitute Market by Segment, Europe, 2020 - 2030
Chart 7-2: Leading Competitors, Orthopedic Bone Graft Substitute Market, Europe, 2023
Chart 9-1: Orthopedic Cell Therapy Market by Segment, Europe, 2020 - 2030
Chart 9-2: Leading Competitors, Orthopedic Cell Therapy Market, Europe, 2023
Chart 10-1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 - 2030
Chart 10-2: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2023
Chart 11-1: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 - 2030
Chart 11-2: Leading Competitors, Orthopedic Cartilage Repair Market, Europe, 2023

LIST OF FIGURES

Figure 1-1: Orthopedic Biomaterials Market Share Ranking by Segment, Europe, 2023
Figure 1-2: Companies Researched in This Report
Figure 1-3: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe (1 of 2)
Figure 1-4: Factors Impacting the Orthopedic Biomaterials Market by Segment, Europe (2 of 2)
Figure 1-5: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (1 of 7)
Figure 1-6: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (2 of 7)
Figure 1-7: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (3 of 7)
Figure 1-8: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (4 of 7)
Figure 1-9: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (5 of 7)
Figure 1-10: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (6 of 7)
Figure 1-11: Recent Events in the Orthopedic Biomaterials Market, Europe, 2021 - 2024 (7 of 7)
Figure 1-12: Orthopedic Biomaterials Market Segmentation, Europe (1 of 2)
Figure 1-13: Orthopedic Biomaterials Market Segmentation, Europe (2 of 2)
Figure 1-14: Orthopedic Biomaterials Procedure Segmentation, Europe (1 of 3)
Figure 1-15: Orthopedic Biomaterials Procedure Segmentation, Europe (2 of 3)
Figure 1-16: Orthopedic Biomaterials Procedure Segmentation, Europe (3 of 3)
Figure 1-17: Key Report Updates (1 of 2)
Figure 1-18: Version History
Figure 2-1: Orthopedic Biomaterials Market by Segment, Worst Case Scenario, Europe, 2020 - 2030 (€M)
Figure 2-2: Orthopedic Biomaterials Market by Segment, Base Case Scenario, Europe, 2020 - 2030 (€M)
Figure 2-3: Orthopedic Biomaterials Market by Segment, Best Case Scenario, Europe, 2020 - 2030 (€M)
Figure 3-1: Bone Graft Substitutes Products by Company (1 of 4)
Figure 3-2: Bone Graft Substitutes Products by Company (2 of 4)
Figure 3-3: Bone Graft Substitutes Products by Company (3 of 4)
Figure 3-4: Bone Graft Substitutes Products by Company (4 of 4)
Figure 3-5: Growth Factor Products by Company
Figure 3-6: Cell Therapy Products by Company
Figure 3-7: Hyaluronic Acid Viscosupplementation by Products by Company
Figure 3-8: Cartilage Repair Products by Company
Figure 3-9: Class 2 Device Recall GRAFTON DBM (Gel, Flex, Putty, Matrix, Crunch)
Figure 3-10: Class 2 Device Recall GRAFTON PLUS DBM Paste
Figure 3-11: Class 2 Device Recall Magnifuse Bone Graft
Figure 3-12: Class 2 Device Recall Grafton DBF Inject
Figure 3-13: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty
Figure 3-14: Class 2 Device Recall PROSTIM 10cc INJECTABLE
Figure 3-15: Class 2 Device Recall Opteform Allograft Disc
Figure 3-16: Class 2 Device Recall Bioactive Bone Graft Putty
Figure 3-17: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty
Figure 3-18: ACDF Using Structural Allograft vs. Tritanium C
Figure 3-19: Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications
Figure 3-20: OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
Figure 3-21: Rate of Bony Fusion Using NanoBone(R) Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE)
Figure 3-22: Demineralized Bone Matrix Rotator Cuff Study
Figure 3-23: Clinical Outcomes Associated with the Use of ViviGen(R) for the Treatment of Lumbar Degenerative Disc Disease
Figure 3-24: The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
Figure 3-25: Long-term Safety and Effectiveness of AUGMENT(R) Injectable Bone Graft Compared to Autologous Bone Graft
Figure 3-26: Transforaminal Lumbar Interbody Fusion (TLIF)
Figure 3-27: A Post Market Surveillance on INFUSE Bone Graft
Figure 3-28: Long-term Safety and Effectiveness of AUGMENT(R) Injectable Bone Graft Compared to Autologous Bone Graft
Figure 3-29: Evaluation of the Effectiveness of AMPLEX(R) Compared to Autogenous Bone Grafts
Figure 3-30: Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
Figure 3-31: Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
Figure 3-32: BMAC & Allograft vs BMP-2
Figure 3-33: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC)
Figure 3-34: Platelet Rich Plasma in Knee Osteoarthritis
Figure 3-35: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
Figure 3-36: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain
Figure 3-37: ArtiAid(R) for Knee Osteoarthritis: A Post-market Study
Figure 3-38: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis
Figure 3-39: Euflexxa for the Treatment of Osteoarthritis
Figure 3-40: MONOVISC for Ankle Joint Pain Relief
Figure 3-41: MONOVISC for Shoulder Joint Pain Relief
Figure 3-42: MONOVISC for Hip Joint Pain Relief
Figure 3-43: Comparison of Hyaluronic Acid and Platelet-Rich Plasma Injections
Figure 3-44: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
Figure 3-45: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
Figure 3-46: Phase 2 Clinical Trial of CartiLife(R) in the United States
Figure 3-47: A Study to Evaluate the Efficacy of BioCartilage(R) Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
Figure 4-1: Currency Exchange Rate, 2023
Figure 4-2: Orthopedic Biomaterials Market by Segment, Europe, 2020 - 2030 (€M)
Figure 4-3: Orthopedic Biomaterials Market by Segment, Europe, 2020 - 2030 (US$M)
Figure 4-4: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023 (1 of 2)
Figure 4-5: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2023 (2 of 2)
Figure 4-6: SWOT Analysis, Arthrex
Figure 4-7: SWOT Analysis, Biocomposites
Figure 4-8: SWOT Analysis, Bioventus
Figure 4-9: SWOT Analysis, DePuy Synthes
Figure 4-10: SWOT Analysis, Ferring Pharmaceuticals
Figure 4-11: SWOT Analysis, Isto Biologics
Figure 4-12: SWOT Analysis, Medtronic
Figure 4-13: SWOT Analysis, MTF
Figure 4-14: SWOT Analysis, NuVasive
Figure 4-15: SWOT Analysis, Orthofix
Figure 4-16: SWOT Analysis, Sanofi
Figure 4-17: SWOT Analysis, Stryker
Figure 4-18: SWOT Analysis, Terumo
Figure 4-19: SWOT Analysis, Vericel
Figure 4-20: SWOT Analysis, Zimmer Biomet
Figure 6-1: Orthopedic Biomaterials Procedures by Segment, Europe, 2020 - 2030
Figure 6-2: Orthopedic Biomaterials Procedures by Segment, Europe, 2020 - 2030
Figure 6-3: Orthopedic Bone Grafting Procedures by Country, Europe, 2020 - 2030
Figure 6-4: Orthopedic Bone Grafting Procedures by Material, Europe, 2020 - 2030
Figure 6-5: Orthopedic Bone Grafting Procedures by Indication, Europe, 2020 - 2030 (1 of 2)
Figure 6-6: Orthopedic Bone Grafting Procedures by Indication, Europe, 2020 - 2030 (2 of 2)
Figure 6-7: Cervical Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-8: Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-9: Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-10: Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-11: Hip Procedures by Country, Europe, 2020 - 2030
Figure 6-12: Knee Procedures by Country, Europe, 2020 - 2030
Figure 6-13: Foot Procedures by Country, Europe, 2020 - 2030
Figure 6-14: Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
Figure 6-15: Oncology Procedures by Country, Europe, 2020 - 2030
Figure 6-16: Average Units Used per Procedure by Indication, Europe, 2020 - 2030
Figure 6-17: Allograft Procedures by Country, Europe, 2020 - 2030
Figure 6-18: Allograft Procedures by Indication, Europe, 2020 - 2030 (1 of 2)
Figure 6-19: Allograft Procedures by Indication, Europe, 2020 - 2030 (2 of 2)
Figure 6-20: Allograft Cervical Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-21: Allograft Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-22: Allograft Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-23: Allograft Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-24: Allograft Hip Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
Figure 6-25: Allograft Knee Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
Figure 6-26: Allograft Foot Reconstruction Procedures by Country, Europe, 2020 - 2030
Figure 6-27: Allograft Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
Figure 6-28: Allograft Oncology Procedures by Country, Europe, 2020 - 2030
Figure 6-29: DBM Procedures by Country, Europe, 2020 - 2030
Figure 6-30: DBM Procedures by Indication, Europe, 2020 - 2030
Figure 6-31: DBM Cervical Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-32: DBM Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-33: DBM Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-34: DBM Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-35: DBM Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
Figure 6-36: Synthetic Procedures by Country, Europe, 2020 - 2030
Figure 6-37: Synthetic Procedures by Indication, Europe, 2020 - 2030 (1 of 2)
Figure 6-38: Synthetic Procedures by Indication, Europe, 2020 - 2030 (2 of 2)
Figure 6-39: Synthetic Cervical Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-40: Synthetic Thoracolumbar Spine Procedures by Country, Europe, 2020 - 2030
Figure 6-41: Synthetic Non-Union Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-42: Synthetic Fresh Fracture Trauma Procedures by Country, Europe, 2020 - 2030
Figure 6-43: Synthetic Hip Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
Figure 6-44: Synthetic Knee Large Joint Reconstruction Procedures by Country, Europe, 2020 - 2030
Figure 6-45: Synthetic Foot Reconstruction Procedures by Country, Europe, 2020 - 2030
Figure 6-46: Synthetic Craniomaxillofacial Procedures by Country, Europe, 2020 - 2030
Figure 6-47: Synthetic Oncology Procedures by Country, Europe, 2020 - 2030
Figure 6-48: Orthopedic Bone Grafting Procedures by Care Setting, Europe, 2020 - 2030
Figure 6-49: Orthopedic Growth Factor Procedures by Country, Europe, 2020 - 2030
Figure 6-50: Orthopedic Growth Factor Procedures by Indication, Europe, 2020 - 2030
Figure 6-51: Spine Growth Factor Procedures by Country, Europe, 2020 - 2030
Figure 6-52: Tibial Growth Factor Procedures by Country, Europe, 2020 - 2030
Figure 6-53: Orthopedic Growth Factor Procedures by Care Setting, Europe, 2020 - 2030
Figure 6-54: Orthopedic Cell Therapy Procedures by Country, Europe, 2020 - 2030
Figure 6-55: Orthopedic Cell Therapy Procedures by Material Type, Europe, 2020 - 2030
Figure 6-56: Platelet-Rich Plasma Procedures by Country, Europe, 2020 - 2030
Figure 6-57: Bone Marrow Aspirate Concentrate Procedures by Indication, Europe, 2020 - 2030
Figure 6-58: Orthopedic Cell Therapy Procedures by Care Setting, Europe, 2020 - 2030
Figure 6-59: Hyaluronic Acid Viscosupplementation Total Injections by Country, Europe, 2020 - 2030
Figure 6-60: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Europe, 2020 - 2030 (1 of 2)
Figure 6-61: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, Europe, 2020 - 2030 (2 of 2)
Figure 6-62: Single-Injection Cycles by Country, Europe, 2020 - 2030
Figure 6-63: Two-Injection Cycles by Country, Europe, 2020 - 2030
Figure 6-64: Three-Injection Cycles by Country, Europe, 2020 - 2030
Figure 6-65: Five-Injection Cycles by Country, Europe, 2020 - 2030
Figure 6-66: Hyaluronic Acid Viscosupplementation Procedures by Care Setting, Europe, 2020 - 2030
Figure 6-67: Orthopedic Cartilage Repair Procedures by Type, Europe, 2020 - 2030
Figure 6-68: Orthopedic Cartilage Repair Procedures by Care Setting, Europe, 2020 - 2030
Figure 7-1: Bone Graft Substitute Market by Segment, Europe, 2020 - 2030 (€M)
Figure 7-2: Bone Graft Substitute Market by Segment, Europe, 2020 - 2030 (US$M)
Figure 7-3: Total Bone Graft Substitute Market, Europe, 2020 - 2030
Figure 7-4: Units Sold by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030
Figure 7-5: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (€)
Figure 7-6: Average Selling Price by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (US$)
Figure 7-7: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (€M)
Figure 7-8: Market Value by Country, Total Bone Graft Substitute Market, Europe, 2020 - 2030 (US$M)
Figure 7-9: Allograft Market, Europe, 2020 - 2030
Figure 7-10: Units Sold by Country, Allograft Market, Europe, 2020 - 2030
Figure 7-11: Average Selling Price by Country, Allograft Market, Europe, 2020 - 2030 (€)
Figure 7-12: Average Selling Price by Country, Allograft Market, Europe, 2020 - 2030 (US$)
Figure 7-13: Market Value by Country, Allograft Market, Europe, 2020 - 2030 (€M)
Figure 7-14: Market Value by Country, Allograft Market, Europe, 2020 - 2030 (US$M)
Figure 7-15: Demineralized Bone Matrix Market, Europe, 2020 - 2030
Figure 7-16: Units Sold by Country, Demineralized Bone Matrix Market, Europe, 2020 - 2030
Figure 7-17: Average Selling Price by Country, Demineralized Bone Matrix Market, Europe, 2020 - 2030 (€)
Figure 7-18: Average Selling Price by Country, Total Demineralized Bone Matrix Market, Europe, 2020 - 2030 (US$)
Figure 7-19: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2020 - 2030 (€M)
Figure 7-20: Market Value by Country, Total Demineralized Bone Matrix Market, Europe, 2020 - 2030 (US$M)
Figure 7-21: Synthetic Market, Europe, 2020 - 2030
Figure 7-22: Units Sold by Country, Synthetic Market, Europe, 2020 - 2030
Figure 7-23: Average Selling Price by Country, Total Synthetic Market, Europe, 2020 - 2030 (€)
Figure 7-24: Average Selling Price by Country, Total Synthetic Market, Europe, 2020 - 2030 (US$)
Figure 7-25: Market Value by Country, Total Synthetic Market, Europe, 2020 - 2030 (€M)
Figure 7-26: Market Value by Country, Total Synthetic Market, Europe, 2020 - 2030 (US$M)
Figure 7-27: Total Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030 (1 of 2)
Figure 7-28: Total Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030 (2 of 2)
Figure 7-29: Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
Figure 7-30: Spine Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
Figure 7-31: Units Sold by Country, Cervical Spine Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-32: Units Sold by Country, Thoracolumbar Spine Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-33: Trauma Allograft Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
Figure 7-34: Units Sold by Country, Non-Union Trauma Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-35: Units Sold by Country, Fresh Fracture Trauma Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-36: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 - 2030
Figure 7-37: Units Sold by Country, Hip Large Joint Reconstruction Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-38: Units Sold by Country, Knee Large Joint Reconstruction Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-39: Units Sold by Country, Foot Reconstruction Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-40: Units Sold by Country, Craniomaxillofacial Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-41: Units Sold by Country, Oncology Allograft Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-42: Demineralized Bone Matrix Allograft Units Sold by Indication, Europe, 2020 - 2030
Figure 7-43: Spine Demineralized Bone Matrix Allograft Units Sold by Anatomy, Europe, 2020 - 2030
Figure 7-44: Units Sold by Country, Cervical Spine Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
Figure 7-45: Units Sold by Country, Thoracolumbar Spine Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
Figure 7-46: Trauma Demineralized Bone Matrix Allograft Units Sold by Anatomy, Europe, 2020 - 2030
Figure 7-47: Units Sold by Country, Non-Union Trauma Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
Figure 7-48: Units Sold by Country, Fresh Fracture Trauma Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
Figure 7-49: Units Sold by Country, Craniomaxillofacial Demineralized Bone Matrix Allograft, Europe, 2020 - 2030
Figure 7-50: Synthetic Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
Figure 7-51: Spine Synthetic Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 - 2030
Figure 7-52: Units Sold by Country, Cervical Spine Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-53: Units Sold by Country, Thoracolumbar Spine Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-54: Trauma Synthetic Bone Graft Substitute Units Sold by Indication, Europe, 2020 - 2030
Figure 7-55: Units Sold by Country, Non-Union Trauma Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-56: Units Sold by Country, Fresh Fracture Trauma Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-57: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold by Anatomy, Europe, 2020 - 2030
Figure 7-58: Units Sold by Country, Hip Large Joint Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-59: Units Sold by Country, Knee Large Joint Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-60: Units Sold by Country, Foot Reconstruction Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-61: Units Sold by Country, Craniomaxillofacial Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-62: Units Sold by Country, Oncology Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-63: Units Sold by Country, Generation 1 Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-64: Units Sold by Country, Generation 2 Synthetic Bone Graft Substitute, Europe, 2020 - 2030
Figure 7-65: Leading Competitors by Country, Orthopedic Bone Graft Substitute Market, Europe, 2023
Figure 7-66: Leading Competitors by Segment, Orthopedic Bone Graft Substitute Market, Europe, 2023
Figure 8-1: Orthopedic Growth Factor Market by Segment, Europe, 2020 - 2030 (€M)
Figure 8-2: Orthopedic Growth Factor Market by Segment, Europe, 2020 - 2030 (US$M)
Figure 8-3: Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-4: Units Sold (5 cc) by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-5: Average Selling Price by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€)
Figure 8-6: Average Selling Price by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$)
Figure 8-7: Market Value by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€M)
Figure 8-8: Market Value by Country, Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$M)
Figure 8-9: Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-10: Units Sold (5 cc) by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-11: Average Selling Price by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€)
Figure 8-12: Average Selling Price by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$)
Figure 8-13: Market Value by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€M)
Figure 8-14: Market Value by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$M)
Figure 8-15: Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-16: Units Sold (5 cc) by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-17: Average Selling Price by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€)
Figure 8-18: Average Selling Price by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$)
Figure 8-19: Market Value by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (€M)
Figure 8-20: Market Value by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030 (US$M)
Figure 8-21: Units Sold (5 cc) by Country, Spine Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-22: Units Sold (5 cc) by Country, Tibial Orthopedic Growth Factor Market, Europe, 2020 - 2030
Figure 8-23: Leading Competitors by Country, Orthopedic Growth Factor Market, Europe, 2023
Figure 9-1: Orthopedic Cell Therapy Market by Segment, Europe, 2020 - 2030 (€M)
Figure 9-2: Orthopedic Cell Therapy Market by Segment, Europe, 2020 - 2030 (US$M)
Figure 9-3: Platelet-Rich Plasma Market, Europe, 2020 - 2030
Figure 9-4: Units Sold (10 cc) by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030
Figure 9-5: Average Selling Price by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (€)
Figure 9-6: Average Selling Price by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (US$)
Figure 9-7: Market Value by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (€M)
Figure 9-8: Market Value by Country, Platelet-Rich Plasma Market, Europe, 2020 - 2030 (US$M)
Figure 9-9: Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
Figure 9-10: Units Sold (10 cc) by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
Figure 9-11: Average Selling Price by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (€)
Figure 9-12: Average Selling Price by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (US$)
Figure 9-13: Market Value by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (€M)
Figure 9-14: Market Value by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030 (US$M)
Figure 9-15: Units Sold by Country, Soft-Tissue Platelet-Rich Plasma, Europe, 2020 - 2030
Figure 9-16: Units Sold by Country, Spine Platelet-Rich Plasma, Europe, 2020 - 2030
Figure 9-17: Units Sold by Country, Cardiac Platelet-Rich Plasma, Europe, 2020 - 2030
Figure 9-18: Units Sold by Country, Orthopedic Platelet-Rich Plasma, Europe, 2020 - 2030
Figure 9-19: Units Sold by Country, Plastics Platelet-Rich Plasma, Europe, 2020 - 2030
Figure 9-20: Units Sold (10cc) by Country, Spine Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
Figure 9-21: Units Sold (10cc) by Country, Soft-Tissue Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
Figure 9-22: Units Sold (10 cc) by Country, Trauma Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
Figure 9-23: Units Sold (10 cc) by Country, Joint Reconstruction Bone Marrow Aspirate Concentrate Market, Europe, 2020 - 2030
Figure 9-24: Leading Competitors by Country, Orthopedic Cell Therapy Market, Europe, 2023
Figure 9-25: Leading Competitors by Segment, Orthopedic Cell Therapy Market, Europe, 2023
Figure 9-26: Leading Competitors by Country, Platelet-Rich Cell Therapy Market, Europe, 2023
Figure 9-27: Leading Competitors by Country, Bone Marrow Aspirate Concentrate Market, Europe, 2023
Figure 10-1: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 - 2030 (€M)
Figure 10-2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2020 - 2030 (US$M)
Figure 10-3: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030
Figure 10-4: Units Sold (Cycles) by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030
Figure 10-5: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (€)
Figure 10-6: Average Selling Price by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (US$)
Figure 10-7: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (€M)
Figure 10-8: Market Value by Country, Total Hyaluronic Acid Viscosupplementation Market, Europe, 2020 - 2030 (US$M)
Figure 10-9: Single-Injection Market, Europe, 2020 - 2030
Figure 10-10: Units Sold (Cycles) by Country, Single-Injection Market, Europe, 2020 - 2030
Figure 10-11: Average Selling Price by Country, Single-Injection Market, Europe, 2020 - 2030 (€)
Figure 10-12: Average Selling Price by Country, Single-Injection Market, Europe, 2020 - 2030 (US$)
Figure 10-13: Market Value by Country, Single-Injection Market, Europe, 2020 - 2030 (€M)
Figure 10-14: Market Value by Country, Single-Injection Market, Europe, 2020 - 2030 (US$M)
Figure 10-15: Two-Injection Market, Europe, 2020 - 2030
Figure 10-16: Units Sold (Cycles) by Country, Two-Injection Market, Europe, 2020 - 2030
Figure 10-17: Average Selling Price by Country, Two-Injection Market, Europe, 2020 - 2030 (€)
Figure 10-18: Average Selling Price by Country, Two-Injection Market, Europe, 2020 - 2030 (US$)
Figure 10-19: Market Value by Country, Two-Injection Market, Europe, 2020 - 2030 (€M)
Figure 10-20: Market Value by Country, Two-Injection Market, Europe, 2020 - 2030 (US$M)
Figure 10-21: Three-Injection Market, Europe, 2020 - 2030
Figure 10-22: Units Sold (Cycles) by Country, Three-Injection Market, Europe, 2020 - 2030
Figure 10-23: Average Selling Price by Country, Three-Injection Market, Europe, 2020 - 2030 (€)
Figure 10-24: Average Selling Price by Country, Three-Injection Market, Europe, 2020 - 2030 (US$)
Figure 10-25: Market Value by Country, Three-Injection Market, Europe, 2020 - 2030 (€M)
Figure 10-26: Market Value by Country, Three-Injection Market, Europe, 2020 - 2030 (US$M)
Figure 10-27: Five-Injection Market, Europe, 2020 - 2030
Figure 10-28: Units Sold (Cycles) by Country, Five-Injection Market, Europe, 2020 - 2030
Figure 10-29: Average Selling Price by Country, Five-Injection Market, Europe, 2020 - 2030 (€)
Figure 10-30: Average Selling Price by Country, Five-Injection Market, Europe, 2020 - 2030 (US$)
Figure 10-31: Market Value by Country, Five-Injection Market, Europe, 2020 - 2030 (€M)
Figure 10-32: Market Value by Country, Five-Injection Market, Europe, 2020 - 2030 (US$M)
Figure 10-33: Leading Competitors by Country, Hyaluronic Acid Viscosupplementation Market, Europe, 2023
Figure 11-1: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 - 2030 (€M)
Figure 11-2: Orthopedic Cartilage Repair Market by Segment, Europe, 2020 - 2030 (US$M)
Figure 11-3: Osteochondral Allograft Market, Europe, 2020 - 2030
Figure 11-4: Units Sold by Country, Osteochondral Allograft Market, Europe, 2020 - 2030
Figure 11-5: Average Selling Price by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (€)
Figure 11-6: Average Selling Price by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (US$)
Figure 11-7: Market Value by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (€M)
Figure 11-8: Market Value by Country, Osteochondral Allograft Market, Europe, 2020 - 2030 (US$M)
Figure 11-9: Meniscal Allograft Market, Europe, 2020 - 2030
Figure 11-10: Units Sold by Country, Meniscal Allograft Market, Europe, 2020 - 2030
Figure 11-11: Average Selling Price by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (€)
Figure 11-12: Average Selling Price by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (US$)
Figure 11-13: Market Value by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (€M)
Figure 11-14: Market Value by Country, Meniscal Allograft Market, Europe, 2020 - 2030 (US$M)
Figure 11-15: Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030
Figure 11-16: Units Sold by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030
Figure 11-17: Average Selling Price by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (€)
Figure 11-18: Average Selling Price by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (US$)
Figure 11-19: Market Value by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (€M)
Figure 11-20: Market Value by Country, Autologous Chondrocyte Implantation Market, Europe, 2020 - 2030 (US$M)
Figure 11-21: Osteochondral Autograft Market, Europe, 2020 - 2030
Figure 11-22: Units Sold by Country, Osteochondral Autograft Market, Europe, 2020 - 2030
Figure 11-23: Average Selling Price by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (€)
Figure 11-24: Average Selling Price by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (US$)
Figure 11-25: Market Value by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (€M)
Figure 11-26: Market Value by Country, Osteochondral Autograft Market, Europe, 2020 - 2030 (US$M)
Figure 11-27: Leading Competitors, Orthopedic Cartilage Repair Market, Europe, 2023

Product Code: iDATA_EUOB24_MS

In 2023, the European market for orthopedic biomaterials was valued at over €554 million. This market is projected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching nearly €643 million by 2030. The full report on the European orthopedic biomaterials market includes bone graft substitutes (allografts, demineralized bone matrices (DBMs), and synthetic bone grafts), orthopedic growth factors, cell therapies (bone marrow aspirate concentrate and platelet-rich plasma), hyaluronic acid (HA) viscosupplementation (single-, two-, three-, and five-injection cycles), and orthopedic cartilage repair (osteochondral allografts, meniscal allografts, autologous chondrocyte implantation, and osteochondral autografts).

MARKET DATA HIGHLIGHTS:

Unit sales, average selling prices, market value, and growth trends
Forecasts until 2030 and historical data from 2020
Market drivers and constraints for each segment
Competitive analysis with market shares for each segment
Mergers & acquisitions
Procedure volumes
Company profiles, product portfolios, and SWOT analysis for top competitors

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET TRENDS

Key demographic trends continue to drive the European orthopedic biomaterials market. A notable factor is the rising incidence of osteoarthritis (OA) in the spine, particularly as the population ages, leading to an increasing number of spinal fusion procedures. With the aging population, driven by the retirement of the first wave of baby boomers starting in 2008, there has been a growing demand for treatments addressing arthritis and degenerative disc disease. This has led to an increased need for bone graft substitutes. Additionally, the prevalence of degenerative diseases is further accelerated by rising obesity rates, driving demand for orthopedic biomaterials and associated procedures. These trends are expected to propel market growth during the forecast period.

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKET SHARE INSIGHTS (2023)

Fidia maintained its leadership position in the European orthopedic biomaterials market, bolstered by the strong performance of its HA viscosupplementation products, Hyalubrix(R) and Hyalgan(R).

Medtronic ranked as the second-largest player, largely due to its dominance in the orthopedic growth factor market with its INFUSE(TM) product.

Bioventus secured the third-largest market share, primarily as the leading distributor of DUROLANE(R), a single-injection treatment, across Europe.

MARKET SEGMENTATION SUMMARY

Bone Graft Substitutes Market: Includes allografts, demineralized bone matrices (DBMs), and synthetic bone graft substitutes.
Orthopedic Growth Factor Market: Segmented into spine and tibial fracture treatments.
Orthopedic Cell Therapy Market: Includes platelet-rich plasma and bone marrow concentration segments.
Hyaluronic Acid Viscosupplementation Market: Covers single-injection, two-injection, three-injection, and five-injection products.
Orthopedic Cartilage Repair Market: Includes osteochondral allografts, meniscal allografts, autologous chondrocyte implantation (ACI), and osteochondral autografts.

GLOBAL RESEARCH SCOPE SUMMARY

Region: Europe (France, U.K., Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal)
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2022
Quantitative Coverage: Market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
Qualitative Coverage: COVID-19 impact, market growth trends, market constraints, competitive analysis, SWOT for top competitors, mergers & acquisitions, company profiles, product portfolios, FDA recalls, disruptive technologies, disease overviews.
Data Sources: Primary interviews with industry leaders, government physician data, regulatory data, hospital private data, import/export data, iData Research's internal database.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

European Orthopedic Biomaterials Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Trends

Market Developments

Market Segmentation

Procedure Segmentation

Key Report Updates

Version History

research methodology

Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE European Orthopedic Biomaterials Market

2.1 Introduction
- 2.1.1 Treatable Population
2.2 Country Profiles
2.3 Analysis By Market Segment
- 2.3.1 Worst Case Scenario
- 2.3.2 Base Case Scenario
- 2.3.3 Best Case Scenario

Product Assessment

3.1 Introduction
3.2 Product Portfolios
- 3.2.1 Bone Graft Substitutes
- 3.2.2 Growth Factors
  - 3.2.2.1.1 NELL-1 Bone Biologics
  - 3.2.2.1.2 INFUSE(R) by Medtronic
  - 3.2.2.1.3 OsteoAMP(R) by Bioventus Surgical
  - 3.2.2.1.4 OP-1(TM) by Stryker/Olympus Biotech (Delisted)
  - 3.2.2.1.5 The Osteogrow Study
  - 3.2.2.1.6 AUGMENT(R) Bone Graft
  - 3.2.2.1.7 Amplex(R) Osteobiologic Bone Graft Substitute
  - 3.2.2.1.8 i-Factor(TM) Peptide Bone Matrix
- 3.2.3 Cell Therapy
  - 3.2.3.1 Platelet-Rich Plasma
  - 3.2.3.2 Bone Marrow Aspirate Concentrate
- 3.2.4 Hyaluronic Acid Viscosupplementation (HAV)
- 3.2.5 Cartilage Repair
3.3 Regulatory Issues and Recalls
- 3.3.1 Bone Graft Substitute Market FDA Recalls
- 3.3.2 Growth Factor Market FDA Recalls
3.4 Clinical Trials
- 3.4.1 Bone Graft Substitute Market Clinical Trials
- 3.4.2 Growth Factor Market Clinical Trials
- 3.4.3 Cell Therapy Market Clinical Trials
- 3.4.4 Hyaluronic Acid Viscosupplementation Market
- 3.4.5 Cartilage Repair Market Clinical Trials

European Orthopedic Biomaterials Market Overview

4.1 Introduction
4.2 Currency Exchange Rate
4.3 Market Overview & Trend Analysis
4.4 Drivers and Limiters
- 4.4.1 Market Drivers
- 4.4.2 Market Limiters
4.5 Competitive Market Share Analysis
4.6 Mergers and Acquisitions
4.7 Company Profiles
- 4.7.1 Arthrex
- 4.7.2 Biocomposites
- 4.7.3 Bioventus
- 4.7.4 DePuy Synthes
- 4.7.5 Ferring Pharmaceuticals
- 4.7.6 Isto Biologics
- 4.7.7 Medtronic
- 4.7.8 MTF
- 4.7.9 NuVasive
- 4.7.10 Orthofix
- 4.7.11 Sanofi
- 4.7.12 Stryker
- 4.7.13 Terumo
- 4.7.14 Vericel
- 4.7.15 Zimmer Biomet
4.8 SWOT Analysis
- 4.8.1 Arthrex
- 4.8.2 Biocomposites
- 4.8.3 Bioventus
- 4.8.4 DePuy Synthes
- 4.8.5 Ferring Pharmaceuticals
- 4.8.6 Isto Biologics
- 4.8.7 Medtronic
- 4.8.8 MTF
- 4.8.9 NuVasive
- 4.8.10 Orthofix
- 4.8.11 Sanofi
- 4.8.12 Stryker
- 4.8.13 Terumo
- 4.8.14 Vericel
- 4.8.15 Zimmer Biomet

Country Profiles

5.1 Introduction
- 5.1.1 GDP Per Capita
- 5.1.2 Price Index
5.2 Germany
5.3 France
5.4 United Kingdom
5.5 Italy
5.6 Spain
5.7 Benelux
5.8 Scandinavia
5.9 Austria
5.10 Switzerland
5.11 Portugal

Procedure Numbers

6.1 Introduction
6.2 Procedures
- 6.2.1 Orthopedic Bone Grafting Procedures
  - 6.2.1.1 Orthopedic Bone Grafting Procedures by Material
  - 6.2.1.2 Orthopedic Bone Grafting Procedures by Indication
  - 6.2.1.2.1 Average Units Used per Procedure by Indication
  - 6.2.1.3 Allograft Procedures by Indication
  - 6.2.1.4 DBM Procedures by Indication
  - 6.2.1.5 Synthetic Procedures by Indication
  - 6.2.1.6 Orthopedic Bone Grafting Procedures by Care Setting
- 6.2.2 Orthopedic Growth Factor Procedures
  - 6.2.2.1 Orthopedic Growth Factor Procedures by Indication
  - 6.2.2.2 Orthopedic Growth Factor Procedures by Care Setting
- 6.2.3 Orthopedic Cell Therapy Procedures
  - 6.2.3.1 Orthopedic Cell Therapy Procedures by Material Type
  - 6.2.3.2 Platelet-Rich Plasma Procedures
  - 6.2.3.3 Bone Marrow Aspirate Concentrate Procedures
  - 6.2.3.1 Orthopedic Cell Therapy Procedures by Care Setting
- 6.2.4 Hyaluronic Acid Viscosupplementation Procedures
  - 6.2.4.1 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle
  - 6.2.4.1 Hyaluronic Acid Viscosupplementation Procedures by Care Setting
- 6.2.5 Orthopedic Cartilage Repair Procedures
  - 6.2.5.1 Orthopedic Cartilage Repair Procedures by Type
  - 6.2.5.2 Orthopedic Cartilage Repair Procedures by Care Setting

orthopedic Bone Graft Substitute Market

7.1 Introduction
7.2 Market Overview
7.3 Market Analysis and Forecast
- 7.3.1 Total Bone Graft Substitute Market
- 7.3.2 Allograft Bone Graft Substitute Market
- 7.3.3 Demineralized Bone Matrix Bone Graft Substitute Market
- 7.3.4 Synthetic Bone Graft Substitute Market
7.4 Unit Analysis
- 7.4.1 Total Bone Graft Substitute Unit Analysis
- 7.4.2 Allograft Bone Graft Substitute Unit Analysis
  - 7.4.2.1 Allograft Bone Graft Substitute Units Sold by Indication
  - 7.4.2.1.1 Spine Allograft Bone Graft Substitute Units Sold by Anatomy
  - 7.4.2.1.2 Trauma Allograft Bone Graft Substitute Units Sold by Anatomy
  - 7.4.2.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold by Anatomy
  - 7.4.2.1.4 Foot Reconstruction Allograft Bone Graft Substitute Units Sold
  - 7.4.2.1.5 Craniomaxillofacial Allograft Bone Graft Substitute Units Sold
  - 7.4.2.1.6 Oncology Allograft Bone Graft Substitute Units Sold
- 7.4.3 Demineralized Bone Matrix Allograft Unit Analysis
  - 7.4.3.1 Demineralized Bone Matrix Allograft Units Sold by Indication
  - 7.4.3.1.1 Spine Demineralized Bone Matrix Allograft Units Sold by Anatomy
  - 7.4.3.1.2 Trauma Demineralized Bone Matrix Allograft Units Sold by Anatomy
  - 7.4.3.1.3 Craniomaxillofacial Demineralized Bone Matrix Allograft Units Sold
- 7.4.4 Synthetic Bone Graft Substitute Unit Analysis
  - 7.4.4.1 Synthetic Bone Graft Substitute Units Sold by Indication
  - 7.4.4.1.1 Spine Synthetic Bone Graft Substitute Units Sold by Anatomy
  - 7.4.4.1.2 Trauma Synthetic Bone Graft Substitute Units Sold by Anatomy
  - 7.4.4.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold by Anatomy
  - 7.4.4.1.4 Foot Reconstruction Synthetic Bone Graft Substitute Units Sold
  - 7.4.4.1.5 Craniomaxillofacial Synthetic Bone Graft Substitute Units Sold
  - 7.4.4.1.6 Oncology Synthetic Bone Graft Substitute Units Sold
  - 7.4.4.2 Synthetic Bone Graft Substitute Market by Generation Type
  - 7.4.4.2.1 Generation 1 Synthetic Bone Graft Substitute Market
  - 7.4.4.2.2 Generation 2 Synthetic Bone Graft Substitute Market
7.5 Drivers and Limiters
- 7.5.1 Market Drivers
- 7.5.2 Market Limiters
7.6 Competitive Market Share Analysis

ORthopedic Growth Factor Market

8.1 Introduction
- 8.1.1 BMP-2 (Medtronic)
8.2 Market Overview
8.3 Market Analysis and Forecast
- 8.3.1 Orthopedic Growth Factor Market
- 8.3.2 Spine Fracture Orthopedic Growth Factor Market
- 8.3.3 Tibial Fracture Orthopedic Growth Factor Market
8.4 Unit Analysis
- 8.4.1 Spine Orthopedic Growth Factor Unit Analysis
- 8.4.2 Tibial Fracture Orthopedic Growth Factor Unit Analysis
8.5 Drivers and Limiters
- 8.5.1 Market Drivers
- 8.5.2 Market Limiters
8.6 Competitive Market Share Analysis

Orthopedic Cell Therapy Market

9.1 Introduction
9.2 Market Overview
9.3 Market Analysis and Forecast
- 9.3.1 Platelet-Rich Plasma Market
- 9.3.2 Bone Marrow Aspirate Concentrate Market
9.4 Unit Analysis
- 9.4.1 Platelet-Rich Plasma Units Sold by Indication
  - 9.4.1.1 Soft-Tissue Platelet-Rich Plasma Units Sold
  - 9.4.1.2 Spine Platelet-Rich Plasma Units Sold
  - 9.4.1.3 Cardiac Platelet-Rich Plasma Units Sold
  - 9.4.1.4 Orthopedic Platelet-Rich Plasma Units Sold
  - 9.4.1.5 Plastics Platelet-Rich Plasma Units Sold
- 9.4.2 Bone Marrow Aspirate Concentrate Units Sold by Indication
  - 9.4.2.1 Spine Bone Marrow Aspirate Concentrate Units Sold
  - 9.4.2.2 Soft-Tissue Bone Marrow Aspirate Concentrate Units Sold
  - 9.4.2.3 Trauma Bone Marrow Aspirate Concentrate Units Sold
  - 9.4.2.4 Joint Reconstruction Bone Marrow Aspirate Concentrate Units Sold
9.5 Drivers and Limiters
- 9.5.1 Market Drivers
- 9.5.2 Market Limiters
9.6 Competitive Market Share Analysis

Hyaluronic Acid Viscosupplementation Market

10.1 Introduction
- 10.1.1 Benefits of Viscosupplementation
- 10.1.2 Synovial Fluid
- 10.1.3 Product Types
10.2 Market Overview
10.3 Market Analysis and Forecast
- 10.3.1 Total Hyaluronic Acid Viscosupplementation Market
- 10.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
- 10.3.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
- 10.3.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
- 10.3.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
10.4 Drivers and Limiters
- 10.4.1 Market Drivers
- 10.4.2 Market Limiters
10.5 Competitive Market Share Analysis

Orthopedic Cartilage Repair Market

11.1 Introduction
- 11.1.1 Anatomy
- 11.1.2 Methods for Cartilage Repair
  - 11.1.2.1 Osteochondral Allograft Transfer
  - 11.1.2.2 Autologous Chondrocyte Implantation (ACI)
  - 11.1.2.3 Meniscal Allograft Transplantation
  - 11.1.2.4 Osteochondral Autograft
11.2 Market Overview
11.3 Market Analysis and Forecast
- 11.3.1 Osteochondral Allograft Market
- 11.3.2 Meniscal Allograft Market
- 11.3.3 Autologous Chondrocyte Implantation Market
- 11.3.4 Osteochondral Autograft Market
11.4 Drivers and Limiters
- 11.4.1 Market Drivers
- 11.4.2 Market Limiters
11.5 Competitive Market Share Analysis

Abbreviations